medical investigations liststuart weitzman returns

Accommodations. connection to land, sea and community.

Visit the Martin Health System Laboratory Resource Directory for Laboratory Information, Specimen Collection Information, Laboratory Forms and more. World-class docs Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing Call 1800 022 222. MedicineNet does not provide medical advice, diagnosis or treatment. It helps in diagnosing or treating some medical conditio A CT scan is a medical procedure carried out by a machine that creates a 3D image of your body by moving in a circular motion around you. See additional information. Further testing is often more expensive, dangerous, or both. The lungs ability to hold air, to move air in and out, and to exchange oxygen and carbon dioxide is measured with pulmonary function tests. Tissue samples are removed and examined, usually with a microscope. Studies have shown that people with high cholesterol can reduce their risk for heart disease by lowering their cholesterol. While screening tests are not 100% accurate in all cases, it is generally more valuable to have the screening tests at the appropriate times, as recommended by your healthcare provider, than to not have them at all. Tests are usually one of the six following types. This coagulation test measures the presence and activity of five different blood clotting factors.

People with blood in their stool may have a cancerous growth indicative of colorectal cancer. present. InsideRadiology provides free and easily accessible, accurate, up to date and credible information about medical imaging tests and procedures. Fecal occult blood is detected by microscopic analysis or by chemical tests for hemoglobin (blood) in the stool. Some organizations, such as the United States Preventive Services Task Force (USPSTF), now recommend against PSA screening. Hearing tests can detect and measure the severity of hearing loss. Many organizations, including the USPSTF, recommend mammography screening for breast cancer every 1 year to 2 years after age 50. Testing is recommended starting at age 50 by many organizations including the American Cancer Society. Doctors weigh the risk of a test against the usefulness of the information it will provide. MedicineNet does not provide medical advice, diagnosis or treatment. Less often, sweat, saliva, and fluid from the digestive tract (such as gastric juices) are analyzed. Advances in medical technology have given doctors access to a wider range of medical imaging tests than ever before to help them diagnose, manage and treat internal conditions. What makes a screening test valuable is its ability to detect potential problems, while minimizing unclear, ambiguous, or confusing results. It is important to understand that when blood is present in a stool sample, it can be due to other noncancerous factors, such as certain medications or foods, gastrointestinal bleeding, or hemorrhoids. Please check and try again, Please enter recipient's A doctor may order these tests as part of a routine checkup, to check for certain diseases and disorders, or to monitor your health. Sometimes a disorder can be treated at the same time a screening or diagnostic test is done. Updates? Brought to you by Merck & Co, Inc., Rahway, NJ, USA (known as MSD outside the US and Canada)dedicated to using leading-edge science to save and improve lives around the world. This test can screen for bleeding abnormalities, and may also be used to monitor medication treatments that prevent the formation of blood clots. For example, electrical activity of the heart is measured with electrocardiography (ECG), and electrical activity of the brain is measured with electroencephalography (EEG). Unable to find your location.

This website is certified by the Health On The Net (HON) foundation, the standard for trustworthy health (See alsoddiagnosis; medicine; pathology.). Referrals made easy We are vaccinating all eligible patients. Only Pathology reports available online. We currently support Microsoft Edge, Chrome, Firefox and Safari. Usually, cells from skin, blood, or bone marrow are analyzed.

Read more on Consumers Health Forum of Australia website, The word "X-ray" or "scan" will often be used by the doctor while talking about a test or treatment for your child, Read more on Sydney Children's Hospitals Network website. This list is not exhaustive but might be useful as a guide. 2018 Dr Lal PathLabs. Omissions? Ordinary x-rays are the most common imaging tests. While every effort has been made to follow citation style rules, there may be some discrepancies. mean. We'll help you find the best provider for your child. P.O. The examination often focuses on finding abnormal cells that may provide evidence of inflammation or of a disorder, such as cancer. Hemoglobin A1CThis test is used to diagnose and monitor diabetes. This blood test measures the prostate specific antigen (PSA) levels in the blood. Medical problem? Copyright 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. Read more on Diagnostic Imaging Pathways website, Why and when to get tested for total protein. The link you have selected will take you to a third-party website. These tests provide a picture of the inside of the bodyin its entirety or only of certain parts ( see Overview of Imaging Tests Overview of Imaging Tests Imaging tests provide a picture of the bodys interiorof the whole body or part of it. Explore our network of care for kids, from the tiniest to teens and young adults. Liver PanelThe liver panel is a combination of tests used to assess liver function and establish the possible presence of liver tumors. Please confirm that you are not located inside the Russian Federation. The tests are classified by speciality field allowing to know in which ward of hospital or by which specialist doctor are usually these tests performed. Click the "MyChart" button to access Martin Health Physician Group providers and select medical records from anywhere. UrinalysisOften the first lab test performed, this is a general screening test used to check for early signs of disease. Terms of Use. Pap smears are samples of cells taken from the cervix in women to look for cellular changes indicative of cervical cancer. Let us know if you have suggestions to improve this article (requires login). Support for this browser is being discontinued for this site. There is a total of 5 errors on this form, details are below. Sometimes a test is used for more than one purpose. CulturesCultures are used to test for diagnosis and treatment of infections. Endoscopy usually consists of passing the viewing tube through an existing body opening, such as the following: Nose: To examine the voice box (laryngoscopy) or the lungs (bronchoscopy), Mouth: To examine the esophagus (esophagoscopy), stomach (gastroscopy), and small intestine (upper gastrointestinal endoscopy), Anus: To examine the large intestine, rectum, and anus (coloscopy), Urethra: To examine the bladder (cystoscopy), Vagina: To examine the uterus (hysteroscopy). Pill Identifier Tool Quick, Easy, Pill Identification, Drug Interaction Tool Check Potential Drug Interactions, Pharmacy Locator Tool Including 24 Hour, Pharmacies. MedTerms medical dictionary is the medical terminology for MedicineNet.com. Additionally, individuals without symptoms of diabetes should be screened if they are overweight or obese and have one or more additional diabetes risk factors. The following are some examples of common screening tests: Cholesterol is a waxy substance that can be found in all parts of the body. 1996-2021 MedicineNet, Inc. All rights reserved. Please check and try again. Be sure to consult your healthcare provider regarding the appropriate timing and frequency of all screening tests based on your age, overall health, and medical history. Learn more about the Merck Manuals and our commitment to Global Medical Knowledge. medical test is a medical procedure performed to detect, diagnose, or monitor diseases, disease processes, susceptibility, or to determine a course of treatment. This is a list of medical tests and procedures used to obtain health information and diagnose pathological and nonpathological conditions of the human body. Cholesterol and other fats are transported in the bloodstream in the form of spherical particles, called lipoproteins. It aids in the production of cell membranes, some hormones, and vitamin D. The cholesterol in the blood comes from 2 sources: the food you eat and production in your liver. This brochure provides a basic understanding of radiation, its use in medical imaging, the risks and benefits, and the safety factors built into imaging procedures. Fluid that surrounds the spinal cord and brain (cerebrospinal fluid). A large number of tests are widely available. Firefox. Masks are required inside all of our care facilities, COVID-19 testing locations on Maryland.gov, Ciccarone Center for the Prevention of Heart Disease. Lipid PanelThe lipid panel is a group of tests used to evaluate cardiac risk.

Free Australian health advice you can count on. Often, body functions are measured by recording and analyzing the activity of various organs. Terms of Use. However, the liver produces all of the cholesterol the body needs. Illnesses such as urinary tract infections, pneumonia, strep throat, MRSA and meningitis can be detected and tested for appropriate antibiotic treatment. Cholesterol screening is performed by a blood test. However, because values vary by laboratory, people should consult their doctor about the significance of their own test results rather than refer to this table. Comprehensive Metabolic PanelThis test combines the Basic Metabolic Panel with six more tests for a more comprehensive evaluation of metabolic functions, with a focus on organ systems. Why, when and how to get a cervical screening test. Find out who needs a hearing test, types of hearing tests and how much they cost. healthdirect's information and advice are developed and managed within a rigorous Tests are done for a variety of reasons, including, Evaluating the severity of a disorder so that treatment can be planned. Box 9010, Stuart, FL 34995, Laboratory Services at Cleveland Clinic Martin Health. Thyroid Stimulating HormoneThis test screens and monitors the function of the thyroid. Best in Northern CA Tissues that are commonly examined include skin, breast, lung, liver, kidney, and bone. This page aggregates information that directly links to Pathology Tests Explained. All Right Reserved. Some organizations also recommend HPV (human papilloma virus) screening in certain populations during the Pap smear. Learn more about the b A PET (positron emission tomography) scan is an imaging test used to diagnose certain diseases. Tools are often passed through a channel in the endoscope. My Doctor Says I Have Dense Breasts: What Are Dense Breasts? 17-HYDROXYPROGESTERONE NEWBORN SCREEN; CAH SCREEN, 17-HYDROXYCORTICOSTEROIDS (17-OHCS) & 17-KETOSTEROIDS, 24 HOUR URINE, 17-HYDROXYPROGESTERONE (17OHP) STIMULATION BY ACTH, 17-HYDROXYCORTICOSTEROIDS (17-OHCS), 24 HOUR URINE, 5-AMINOLEVULINIC ACID (5-ALA), 24 HOUR URINE, 5-HIAA (5-HYDROXY INDOLE ACETIC ACID), 24 HOUR URINE, 5-AMINOLEVULINIC ACID (5-ALA), RANDOM URINE, 5 - HIAA (5-HYDROXY INDOLE ACETIC ACID), RANDOM URINE, ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP, ACETYLCHOLINE RECEPTOR (ACHR) BLOCKING ANTIBODY, ACETYLCHOLINE RECEPTOR (ACHR) MODULATING ANTIBODY, ANTI-ds DNA ANTIBODY CRITHIDIA, IFA IN DILUTIONS, ACETYLCHOLINE RECEPTOR (ACHR) BINDING ANTIBODY, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), SERUM, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), CSF, ANTI MULLERIAN HORMONE (AMH) ULTRASENSITIVE; MENOCHECK, ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) PANEL, SERUM, ANCA (ANTI NEUTROPHIL CYTOPLASMIC ANTIBODIES) POSITIVE REFLEX TO ANCA- MPO & ANCA-PR3, ACUTE LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, CSF, ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CYTOGENETICS PANEL, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, SERUM, ACUTE MYELOID LEUKEMIA (AML) CYTOGENETICS PANEL, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, SERUM, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, CSF, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) REFLEX TO ENA PROFILE, ADDON-SARS COV-2 (COVID-19) TOTAL ANTIBODIES, SERUM, ADENOVIRUS ANTIGEN FOR GASTROENTERITIS, STOOL, ADENOVIRUS ANTIGEN FOR RESPIRATORY INFECTIONS, ADRB2 GENOTYPING FOR BETA-2 AGONIST RESPONSIVENESS, ANTI THYROID PEROXIDASE ANTIBODY; ANTI TPO, ALCOHOL BIOMARKERS: ETHYL GLUCURONIDE (EtG) & ETHYL SULPHATE (EtS), URINE, ARTHRITIS & AUTOIMMUNITY AWARENESS (EIA ) SCREENING PACKAGE AAA, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgA, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) PANEL IgA & IgG, ALLERGY: ASTHMA / RHINITIS SCREENING PANEL, ADULT, ALKALINE PHOSPHATASE, BONE-SPECIFIC; BSAP, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgG, ALLERGY: WHEEZE / RHINITIS SCREENING PANEL PEDIATRIC, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) PANEL, ALLERGY: ECZEMA PANEL FOR NON-VEGETARIANS, AMINO ACID NON-KETOTIC HYPERGLYCINEMIA PANEL QUANTITATIVE, CSF & PLASMA, AMINO ACID QUANTITATIVE, CSF: 45 AMINO ACIDS / FULL PANEL, ALLERGY: ECZEMA SCREENING PANEL, PEDIATRIC, AMINO ACIDS MAPLE SYRUP URINE DISEASE (MSUD) PANEL, PLASMA, ALLERGY: FOOD SCREENING PANEL FOR INDIAN POPULATION, AMINO ACIDS QUALITATIVE ONE DIMENSIONAL, URINE, AMINO ACIDS QUALITATIVE TWO DIMENSIONAL, URINE, ALLERGY: INHALATION SCREENING PANEL FOR INDIAN POPULATION, AMINO ACIDS QUANTITATIVE, BLOOD: 10 AMINO ACIDS, AMINO ACIDS QUANTITATIVE, PLASMA: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE URINE: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE, URINE & PLASMA: 45 AMINO ACIDS / FULL PANEL, ALLERGY: BERMUDA GRASS (Cynodon dactylon / Doob), AML ETO t(8;21) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, AML ETO t(8;21) GENE REARRANGEMENT PCR QUALITATIVE, ALLERGY: WHEEZE / RHINITIS COMPREHENSIVE PANEL, ADULT, ALLERGY: WHEEZE / RHINITIS COMPREHENSIVE PANEL, PEDIATRIC, ALLERGY: PEDIATRIC FOOD & INHALATION SCREENING PANEL FOR INDIAN POPULATION, ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), EIA, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) END POINT TITRE, ALLERGY: COMMON PIGWEED (Kantewali Chauli), ALLERGY SPECIFIC IgG: ALTERNARIA ALTERNATA, ANCA (ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES) EXTENDED PROFILE IgG, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA, ASPERGILLUS ANTIBODIES PANEL IgG & IgM, SERUM, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA IN DILUTIONS, ANCA-MPO (ANTI MYELOPEROXIDASE ANTIBODIES), EIA, ANCA-PR3 (SERIN PROTEINASE 3 ANTIBODIES), EIA, AUTOIMMUNE BULLOUS DERMATOSES PROFILE IgG, AUTO IMMUNE ENCEPHALITIS PANEL, SERUM & CSF, AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL, ALLERGY: JOHNSON GRASS (Sorghum halepense / Jowar), ASPIRIN RESISTANCE (11-DEHYDROTHROMBOXANE B2), ALLERGY SPECIFIC IgG: CLADOSPORIUM HERBARUM, ANTI-NMO (NEUROMYELITIS OPTICA ) ANTIBODY / AQUAPORIN 4, ALLERGY SPECIFIC IgG: PENICILLIUM CHRYSOGENUM, ALLERGY: MUG WORT (Artemisia vulgaris / Barna), ALLERGY SPECIFIC IgG: PIGEON SERUM PROTEINS, FEATHERS & DROPPINGS, BOH (BAD OBSTETRIC HISTORY) ADVANCED PANEL, BOH (BAD OBSTETRIC HISTORY) EXTENDED PANEL, BETA CROSSLAPS; BETA CTx; COLLAGEN TYPE I C-TELOPEPTIDE, BIOFIRE GI (GASTROINTESTINAL) PANEL, STOOL, BIOFIRE ME (MENINGOENCEPHALITIS) PANEL, CSF, BIOTINIDASE ACTIVITY QUANTITATIVE, BLOOD, BRCA1 & BRCA2 MUTATION COMPREHENSIVE PANEL, BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL, BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE, BCR-ABL GENE REARRANGEMENT PCR QUANTITATIVE, BETA-2 GLYCOPROTEIN 1 PANEL IgG, IgM & IgA, BLOOD GLUCOSE R + CHOLESTEROL TOTAL+ HB% + TSH, BUCCAL SMEAR FOR BARR BODIES (SEX CHROMATIN), BETA CROSSLAPS; BETA CTx; COLLAGEN TYPE 1C-TELOPEPTIDE, BLOOD PICTURE; PERIPHERAL BLOOD SMEAR EXAMINATION, C1 ESTERASE INHIBITOR FUNCTIONAL; C1 INACTIVATOR FUNCTIONAL, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 DRUGS PANEL, CHROMOSOME ANALYSIS HIGH RESOLUTION, NEONATAL, C1 ESTERASE INHIBITOR PROTEIN QUANTITATION; C1 INHIBITOR QUANTITATIVE, CULTURED AFB ANTITUBERCULAR DST, RAPID 11 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 12 DRUGS PANEL, CHROMOSOME ANALYSIS (KARYOTYPE) COUPLE, BLOOD, CULTURED AFB ANTITUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 4 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, AMIKACIN, CULTURED AFB ANTITUBERCULAR DST, CAPREOMYCIN, CULTURED AFB ANTITUBERCULAR DST, CLOFAZIMINE, CULTURED AFB ANTITUBERCULAR DST, CYCLOSERINE, CULTURED AFB ANTITUBERCULAR DST, ETHAMBUTOL, CULTURED AFB ANTITUBERCULAR DST, ETHIONAMIDE, CULTURED AFB ANTITUBERCULAR DST, ISONIAZID, CULTURED AFB ANTITUBERCULAR DST, KANAMYCIN, CULTURED AFB ANTITUBERCULAR DST, LEVOFLOXACIN, CA 27.29 & CA 15.3; BREAST CANCER MARKERS PANEL, CULTURED AFB ANTITUBERCULAR DST, MOXIFLOXACIN, CULTURED AFB ANTITUBERCULAR DST, OFLOXACIN, CHIMERISM PRE-ENGRAFTMENT DONOR & RECIPIENT, CHIMERISM SPLIT CELL ANALYSIS - MYELOID CELL (CD15), CULTURED AFB ANTITUBERCULAR DST, PYRAZINAMIDE, CHIMERISM SPLIT CELL ANALYSIS - T Cell (CD3), CULTURED AFB ANTITUBERCULAR DST, RIFAMPICIN, CHIMERISM SPLIT CELL ANALYSIS - B CELL (CD19), CALCITONIN STIMULATION BY CALCIUM - PENTAGASTRIN, CULTURED AFB ANTITUBERCULAR DST, STREPTOMYCIN, CULTURED ANAEROBIC BACTERIA IDENTIFICATION, CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE, CULTURE ESBL (EXTENDED SPECTRUM BETA-LACTAMASE) SCREENING, CULTURE MRSA (METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS) SCREENING, CANCER TARGETED GENE PANEL: COLON / COLORECTAL, CULTURE, MYCOBACTERIUM ATYPICAL(NON TUBERCULOUS MYCOBACTERIUM-NTM), CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST), CYTOMEGALOVIRUS (CMV) ANTIBODIES PANEL, IgG & IgM, CANCER TARGETED GENE PANEL : LUNG WITH PDL-1 (DAKO), CULTURE WATER: PRESUMPTIVE COLIFORM COUNT, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA CONFIRMATION, URINE, CYTOMEGALOVIRUS (CMV) DNA, QUANTITATIVE PCR, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA SCREEN, URINE, CARDIO IQ LIPOPROTEIN FRACTIONATION, ION MOBILITY, CYSTICERCOSIS (TAENIA SOLIUM) ANTIBODY, IgG, COCAINE AND METABOLITE CONFIRMATION, URINE, CARDIOLIPIN ANTIBODIES PANEL IgG, IgA & IgM, CYSTIC FIBROSIS MUTATION DETECTION, COMPREHENSIVE, CYSTIC FIBROSIS MUTATION DETECTION, DELTA 508, COLLAGEN CROSS-LINKED N-TELOPEPTIDE (NTx), RANDOM URINE, CHROMOSOME INTERPHASE PROFILING, AMNIOTIC FLUID, CHROMOSOME INTERPHASE PROFILING, PRODUCTS OF CONCEPTION, CHROMOFIC CHROMOSOME SNP MICROARRAY 750K, HIGH RESOLUTION, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, CONVENTIONAL, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, LIQUID BASED, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRENATAL, CATECHOLAMINES FRACTIONATED, 24-HOUR URINE, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRODUCTS OF CONCEPTION, CHROMOSOME XON MICROARRAY, HIGH RESOLUTION, CYTOMEGALOVIRUS, INTERFERON GAMMA RELEASE ASSAY (IGRA), CATECHOLAMINES FRACTIONATED, RANDOM URINE, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PROGNOSTIC PANEL, COMPLETE BLOOD COUNT ADVANCED; CBC ADVANCED, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION COMPREHENSIVE PANEL, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION PANEL 1, COMPREHENSIVE DRUG METABOLISM PROFILE -118 DRUGS, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION PANEL 2, CULTURE AEROBIC BRONCHOALVEOLAR LAVAGE (BAL), CIRCULATING TUMOR CELLS (CTC) FOR BREAST CANCER, CIRCULATING TUMOR CELLS (CTC) FOR COLORECTAL CANCER, CULTURE AEROBIC ENDOTRACHEAL (ET) SECRETIONS, CIRCULATING TUMOR CELLS (CTC) FOR PROSTATE CANCER, CONGENITAL HYPOTHYROIDISM CONFIRMATORY PANEL, SERUM, CKD (CHRONIC KIDNEY DISEASE) MANAGEMENT PANEL, CULTURE AEROBIC MISCELLANEOUS WITH GRAM STAIN, CORTISOL SERUM: MORNING & EVENING SAMPLES, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT HIGH DOSE, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE, CULTURED AEROBIC BACTERIA IDENTIFICATION AND SENSITIVITY, CULTURED AFB ANTITUBERCULAR DST, RAPID 16 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, AMOXYCLAV, CULTURED AFB ANTITUBERCULAR DST, LINEZOLID, CULTURED AFB ANTITUBERCULAR DST, RAPID 20 DRUGS PANEL, CULTURED AFB DRUG RESISTANT (DR MYCOBACTERIUM) ANTI-TUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR RAPID GROWERS, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR SLOW GROWERS, CULTURED AFB ANTITUBERCULAR DST, RAPID 19 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, CLARITHROMYCIN, CRYPTOSPORIDIUM / ISOSPORA IDENTIFICATION, STOOL, CULTURED AFB ANTITUBERCULAR DST, RIFABUTIN, CULTURED AFB ANTI-TUBERCULAR DST, MEROPENEM, CSF LEAKAGE EVALUATION (NASAL/EAR DISCHARGE), CULTURED AFB ANTI-TUBERCULAR DST RAPID, PROTHINAMIDE, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 SECOND LINE DRUGS PANEL, CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 SECOND LINE DRUGS PANEL, CHROMOSOME ANALYSIS, PRODUCTS OF CONCEPTION REFLEX TESTING TO FISH FOR ANEUPLOIDY DETECTION, DPYD (DEOXYPYRIDINOLINE) CROSSLINKS, URINE, DES-GAMMA CARBOXY PROTHROMBIN (DCP)/PIVKA II, SERUM, DRPLA (DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY) GENE ANALYSIS, DIALYSIS SARS-CoV-2 (COVID-19) SCREENING PROFILE, DESMOGLEIN (DSG) 1 AND 3 ANTIBODY IN DILUTION/END POINT TITRE, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) PROFILE, DUCHENNE / BECKER MUSCULAR DYSTROPHY (DMD / BMD) GENE MUTATION, DHEA SULPHATE; DEHYDROEPIANDROSTERONE SULPHATE, DENGUE & CHIKUNGUNYA VIRUSES, PCR QUALITATIVE, DIPHTHERIA-PERTUSSIS-TETANUS ANTIBODY PANEL IgG, DLC (DIFFERENTIAL LEUCOCYTE COUNT), AUTOMATED, DLC (DIFFERENTIAL LEUCOCYTE COUNT), FLUID, ECHINOCOCCUS DETECTION FOR SCOLICES IN HYDATID CYST FLUID, ENTEROHEMORRHAGIC E.COLI VEROTOXIN 1 & 2 ANTIGEN, ECHINOCOCCUS (HYDATID SEROLOGY) IgG, SERUM, EPIDERMAL (PEMPHIGUS) ANTIBODY, IFA IN DILUTIONS, EPISODIC ATAXIA COMPREHENSIVE PROFILE, HOTSPOT, EPSTEIN BARR VIRUS ANTIBODIES TO VIRAL CAPSID ANTIGEN (VCA), IgG & IgM, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA) QUALITATIVE PROFILE, 23 ANTIGENS, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE, EPSTEIN-BARR VIRUS ANTIBODY TO EARLY ANTIGEN (D), IgG, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA) QUALITATIVE PROFILE, 18 ANTIGENS, EPSTEIN-BARR VIRUS ANTIBODY TO NUCLEAR ANTIGEN (EBNA), IgG, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUALITATIVE PROFILE, 15 ANTIGENS, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgG, ENDOMYSIAL ANTIBODY IgA, IFA IN DILUTIONS, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgM, EPSTEIN-BARR VIRUS EARLY RNA (EBER-ISH) IN-SITU-HYBRIDIZATION, EPSTEIN BARR VIRUS (EBV), QUALITATIVE PCR, EPSTEIN BARR VIRUS (EBV), QUANTITATIVE PCR, FISH: PRENATAL COMPREHENSIVE SCREENING PANEL 1, FISH: EWING SARCOMA (EWS), 22q12 (EWSR1) REARRANGEMENT, FISH: FOLLICULAR LYMPHOMA (IGH/BCL2) t(14;18), FACTOR XIII (CLOT SOLUBILITY) FUNCTIONAL, QUALITATIVE, FISH: MDS PANEL CHROMOSOMES 5q, 7q, 8q & 20q, FISH: MICRODELETION DETECTION FOR WILLIAMS SYNDROME, FACTOR VIII / FACTOR IX MUTATION ANALYSIS, FIBRINOGEN DEGRADATION PRODUCTS (FDP), BLOOD, FISH: MULTIPLE MYELOMA WITH POSITIVE SELECTION OF CD138 CELLS, FISH: MULTIPLE MYELOMA EXTENDED PANEL WITH POSITIVE SELECTION OF CD138 CELLS: HYPODIPLOIDY/HYPERDIPLOIDY, FISH - Multiple Myeloma with CD138 positive selection cells ( 5 Probes), FISH: t(8;14) OR MYC/IGH FOR BURKITT & NON-HODGKIN LYMPHOMA, FSH & LH STIMULATION BY GONADOTROPIN RELEASING HORMONE (GnRH), FUNGUS EXAMINATION, ROUTINE: KOH CALCOFLUOR WHITE PREPARATION, FISH: NSCLC (NON-SMALL CELL LUNG CANCER) ALK1 & ROS1, FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION, FLUID EXAMINATION, ROUTINE, CSF/ NASAL FLUID, FISH: PDGFR ALPHA (4q12) GENE REARRANGEMENT, FISH: 22q DELETION OR LSI Di GEORGE / VCFS, FISH: PDGFR BETA (5q33) GENE REARRANGEMENT, FISH: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) EXTENDED PANEL, HYPODIPLOIDY / HYPERDIPLOIDY, FISH: ACUTE MYELOID LEUKEMIA (AML) / MYELODYSPLASTIC SYNDROME (MDS) THERAPY RELATED, FISH: PRENATAL SCREENING PANEL (CHROMOSOMES 13,18, 21, X & Y), FISH: AMNIO ONE PROBE TRISOMY 21 / DOWN SYNDROME, FISH: AMNIO THREE PROBES TRISOMY 18, X & Y, FRAGILE X TREMOR / ATAXIA SYNDROME (FXTAS), FISH: ANEUPLOIDY DETECTION, PRODUCTS OF CONCEPTION (POC) USING CHROMOSOMES 13, 18, 21, X & Y, FISH: SYNOVIAL SARCOMA (SS18/SYT ) 18q11.2 GENE REARRANGEMENT, FISH: BCR / ABL OR PHILADELPHIA TRANSLOCATION, FISH: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) PANEL, FISH: TRISOMY 21 / DOWN SYNDROME, POSTNATAL, GLUCOSE POST PRANDIAL (PP) 2 HOURS POST MEAL, GM2 GANGLIOSIDOSIS QUANTITATIVE, BLOOD; TAY SACHS & SANDHOFF DISEASE, GENEXPERT ULTRA (NEXT GENERATION) MTB WITH RIFAMPICIN RESISTANCE, SEMI QUANTITATIVE PCR, GAD-65 (GLUTAMIC ACID DECARBOXYLASE- 65), IgG, GRAM STAIN FOR BACTERIAL VAGINOSIS (BV), VAGINAL SWAB, GALACTOMANNAN (ASPERGILLUS ANTIGEN), BRONCHOALVEOLAR LAVAGE, GALACTOMANNAN (ASPERGILLUS ANTIGEN), SERUM, GALACTOSEMIA CLASSICAL (TRANSFERASE) QUANTITATIVE, BLOOD, GLIADIN DEAMIDATED ANTIBODIES PANEL, IgA & IgG, GALACTOSEMIA (GALT) GENE MUTATION DETECTION, GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IgG, GFR (GLOMERULAR FILTRATION RATE), ESTIMATED, GLUCOSE CHALLENGE TEST (GCT); GLUCOSE 1 HOUR OBSTETRICAL, GLUCOSE CHALLENGE TEST (GCT) PREGNANCY, 75g GLUCOSE, GLUCOSE FASTING (F) AND POST MEAL (PP), 2 HOURS, GLUCOSE TOLERANCE TEST (GTT) PREGNANCY,100g GLUCOSE, GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IFA, GLUCOSE TOLERANCE TEST (GTT) PREGNANCY, 75g GLUCOSE, HISTOPATHOLOGY SPECIAL STAIN: PHOSPHOTUNGSTIC ACID HEMATOXYLIN (PTAH), HEPATITIS B SURFACE ANTIGEN (HBsAg), QUANTITATIVE, HEPATITIS B VIRAL DNA (HBV DNA) QUANTITATIVE REAL TIME PCR, HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE, HISTOPATHOLOGY SPECIAL STAIN: VAN GIESONS, HCG BETA TOTAL QUANTITATIVE, 24 HOUR URINE, HCG BETA TOTAL QUANTITATIVE, RANDOM URINE, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE REAL TIME PCR, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3, CD4 / CD8 (IMMUNE DEFICIENCY PANEL 2) MARKERS, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 / CD4 (IMMUNE DEFICIENCY PANEL 4) MARKERS, HOMA-IR; INSULIN RESISTANCE INDEX C-PEPTIDE MODEL, HPV, CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA PCR PANEL QUALITATIVE, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I & II IgG ANTIBODIES; DSA-SAB CLASS I & II, HELICOBACTER PYLORI ANTIBODIES PANEL, IgA & IgG, HPV (HUMAN PAPILLOMA VIRUS) DETECTION & GENOTYPING QUALITATIVE PCR, HELICOBACTER PYLORI ANTIGEN, RAPID STOOL TEST, HLA MIXED ANTIBODY SCREEN: PRA CLASS I, II & MICA, HERPES SIMPLEX VIRUS (HSV) 1+2 ANTIBODIES PANEL IgG & IgM, SERUM, HERPES SIMPLEX VIRUS (HSV) 2 ANTIBODIES PANEL IgG & IgM, SERUM, HEMOCHROMATOSIS DETECTION HFE GENOTYPING, HUMAN HERPESVIRUS 6 (HHV6) QUALITATIVE PCR, HUMAN HERPES VIRUS 7 (HHV7) QUALITATIVE PCR, HEMOPHILIA A, HEMOPHILIA B & VON WILLEBRAND DISEASE MUTATION DETECTION, HLA-CELIAC DISEASE: DR-DQB1-DQA1 HAPLOTYPE ASSOCIATION INCLUDING DQ2,DQ8, HLA DNA HIGH RESOLUTION TYPING- A, B, C, DR & DQ, HEPARIN INDUCED THROMBOCYTOPENIA (HIT); ANTI PLATELET FACTOR 4-HEPARIN (PF4-H), IgG QUANTITATIVE, HYPOTHYROIDISM / HASHIMOTO'S DISEASE PANEL, HLA DNA HIGH RESOLUTION TYPING: DQB1 LOCUS, H1N1 (SWINE FLU) QUALITATIVE REAL TIME PCR, HLA DNA HIGH RESOLUTION TYPING: DRB1 LOCUS, HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 10 ANTIGENS PCR, HAINS MYCOBACTERIUM TUBERCULOSIS SECOND LINE DRUG RESISTANCE PROFILE, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 6 ANTIGENS LUMINEX, HLA DNA TYPING FOR KIDNEY / LIVER TRANSPLANT PCR, HLA DNA TYPING HIGH RESOLUTION BY NEXT GENERATION SEQUENCING (NGS), HEPATITIS B CORE ANTIBODY (Anti-HBc), IgM, HEPATITIS B CORE ANTIBODY (Anti-HBc), TOTAL, HAM TEST; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SCREENING TEST, HLA DONOR SPECIFIC IgG ANTIBODIES & PANEL REACTIVE ANTIBODIES SCREEN PROFILE, HHH SYNDROME; HYPERORNITHINEMIA - HYPERAMMONEMIA - HOMOCITRULLINURIA SYNDROME, HISTO / CYTOPATHOLOGY / IMMUNOHISTOCHEMISTRY (IHC) PHOTOMICROGRAPH, HISTO/CYTOPATHOLOGY SLIDE(S) / BLOCK(S) ISSUE, HISTO/CYTOPATHOLOGY, SLIDES (S) / BLOCKS (S) ISSUE, Hepatitis B Surface Antigen (Hbsag) Rapid Screening, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, 6 TO 10 SLIDES, HEPATITIS B SURFACE ANTIGEN (HBsAg) CONFIRMATION, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, 11 TO 20 SLIDES, HEPATITIS B VIRAL DRUG RESISTANCE & GENOTYPING, HISTO/ IHC DIGITIZATION OF SLIDES, UPTO 5 SLIDES, HEPATITIS B VIRAL (HBV DNA) QUANTITATIVE ULTRA, HLA DSA (DONOR SPECIFIC IgG ANTIBODIES) CLASS I & II, HEPATITIS B VIRUS GENOTYPING, DRUG RESISTANCE & QUANTITATIVE PCR, HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN, HEPATITIS B VIRUS PCR QUALITATIVE; HBV DNA PCR QUALITATIVE, HISTOPATHOLOGY BIOPSY: LARGE COMPLEX / CANCER SPECIMEN, HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN, HLA HYPERSENSITIVITY TO ABACAVIR (B*57:01), HLA HYPERSENSITIVITY TO ALLOPURINOL (B*58:01), HLA HYPERSENSITIVITY TO CARBAMAZEPINE & PHENYTOIN (B*15:02), HEPATITIS C VIRAL RNA PCR QUALITATIVE; HCV RNA PCR QUALITATIVE, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY PANEL, HLA-NARCOLEPSY: DRB1*15, DQB1*06:02, DQA1*01:02, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) KIDNEY BIOPSY, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE ULTRA, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C3, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS I QUANTITATIVE, Hepatitis C Virus (HCV) Rapid Screening Test, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgA, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) SCREEN, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgG, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPEINT PANEL1, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgM, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPIENT PANEL1, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C1q, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3, HEPATITIS G VIRUS (HGV) RNA DETECTION PCR, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4, HISTOPATHOLOGY KIDNEY: BIOPSY SECOND OPINION, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I IgG ANTIBODIES; DSA-SAB CLASS I, HISTOPATHOLOGY SPECIAL STAIN: ACID FAST (Z N STAIN), HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS II IgG ANTIBODIES; DSA-SAB CLASS II, HISTOPATHOLOGY SPECIAL STAIN: ALCIAN BLUE, HCG BETA TOTAL QUANTITATIVE, TUMOR MARKER, HERPES SIMPLEX VIRUS (HSV) 1 ANTIBODIES PANEL IgG & IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: COPPER (RHODANINE), HERPES SIMPLEX VIRUS (HSV) 1+2 IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: FONTANA MASSON, HISTOPATHOLOGY SPECIAL STAIN: GOMORIS METHENAMINE SILVER, HERPES SIMPLEX VIRUS (HSV) TYPE 1 & 2 PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: IRON (PERLS STAIN), HERPES SIMPLEX VIRUS (HSV) TYPE 2 PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: MASSON TRICHROME, HBDH; ALPHA-HYDROXYBUTYRATE DEHYDROGENASE, HERPES SIMPLEX VIRUS (HSV) TYPE I PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: MUCICARMINE, HERPES SIMPLEX VIRUS (HSV) 1+2 IgG, SERUM, HISTOPATHOLOGY SPECIAL STAIN: PERIODIC ACID SCHIFF (PAS), HEPATITIS B SURFACE ANTIGEN; HBsAg; AUSTRALIA ANTIGEN, HERPES VIRUS 6 (HHV-6) ANTIBODIES PANEL IgG & IgM, HISTOPATHOLOGY SPECIAL STAIN: AMYLOID (CONGO RED), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: DOUBLE NEGATIVE T CELLS (DNT), IMMUNOHISTOCHEMISTRY: COMPREHENSIVE PANEL, INS MYCOBACTERIUM TUBERCULOSIS FIRST & SECOND LINE DRUG RESISTANCE PROFILE, IMMUNOHISTOCHEMISTRY: CARBONIC ANHYDRASE-9 (CA-9), Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, IMMUNOHISTOCHEMISTRY: LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD16+56, IMMUNOHISTOCHEMISTRY: MYELOPEROXIDASE (MPO), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD34 (STEM CELL) ENUMERATION, IMMUNOHISTOCHEMISTRY: NEUROFILAMENT POLYPEPTIDE, IMMUNOHISTOCHEMISTRY: NEURON SPECIFIC ENOLASE (NSE), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD103, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD10 (CALLA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD117, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD11c, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 1, IMMUNOHISTOCHEMISTRY, POLYOMA BK VIRUS (SV 40), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD123, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 3, IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR (PR), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD13, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 4, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD138, IMMUNOHISTOCHEMISTRY, PROSTATE SPECIFIC ANTIGEN (PSA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD14, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD15, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD19, IMMUNOHISTOCHEMISTRY: GLUTAMINE SYNTHETASE, IMMUNOHISTOCHEMISTRY: SERUM ASSOCIATED AMYLOID (SAA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD1a, IMMUNOHISTOCHEMISTRY: GLYCOPHORIN A (GPA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD20, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD22, IMMUNOHISTOCHEMISTRY: TTF-1 (THYROID TRANSCRIPTION FACTOR-1), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD23, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD25, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD33, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD34, IMMUNOHISTOCHEMISTRY: LUTEINIZING HORMONE (LH), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD36, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD38, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD41a, IMMUNOHISTOCHEMISTRY: 34-BETA E12 / HMW-CK, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD45, IMMUNOHISTOCHEMISTRY: LMW-CK (LOW MOLECULAR WEIGHT CYTOKERATIN), IMMUNOHISTOCHEMISTRY: ACTIN (SMOOTH MUSCLE ACTIN), IMMUNOHISTOCHEMISTRY: LUNG NON-SMALL CELL CARCINOMA (NSCC) PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD61, IMMUNOHISTOCHEMISTRY: AFP (ALPHA FETO PROTEIN), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD64, IMUNOHISTOCHEMISTRY: MICROSATELLITE INSTABILITY PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD79a, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD79b, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD MPO, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: FMC-7, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: GLYCOPHORIN, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: HLA DR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgG HEAVY CHAIN CYTOPLASMIC, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgG HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgM HEAVY CHAIN CYTOPLASMIC, IMMUNOHISTOCHEMISTRY: NEUROENDOCRINE TUMOR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgM HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: KAPPA & LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: ZAP-70, IMMUNOHISTOCHEMISTRY: ESTROGEN RECEPTOR (ER), IMMUNOHISTOCHEMISTRY: BREAST CANCER PANEL 2, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD49d, IBD (INFLAMMATORY BOWEL DISEASE) SCREENING PANEL, IMMUNOHISTOCHEMISTRY: ISOCITRATE DEHYDROGENASE (IDH-1), IMMUNOHISTOCHEMISTRY PD-L1 SP263 (VENTANA), IMMUNOHISTOCHEMISTRY PDL1 SP142 (VENTANA), IgVH HYPERMUTATION ANALYSIS, CONFIRMATORY, INFLUENZA LIKE ILLNESS / ILI SARS-CoV-2 (COVID-19) PANEL, IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA, IMMUNOHISTOCHEMISTRY: CEA (CARCINOEMBRYONIC ANTIGEN), IMMUNOHISTOCHEMISTRY: HER-2 / ERBB2 BREAST, IMMUNOHISTOCHEMISTRY: CHROMOGRANIN-A (CGA), IMMIGRATION / IMMUNIZATION CHECK PANEL, ADVANCED, IMMIGRATION / IMMUNIZATION CHECK PANEL BASIC, IMMUNOHISTOCHEMISTRY: CYTOMEGALOVIRUS (CMV), IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 19 (CK-19), IMMUNOHISTOCHEMISTRY: CYTOKERATIN-20 (CK-20), IMMUNOHISTOCHEMISTRY: THROMBOSPONDIN (THSD7A), IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 7 (CK-7), IMMUNOHISTOCHEMISTRY: THYROID CARCINOMA PANEL, IMMUNOHISTOCHEMISTRY: CYTOKERATIN (PANCYTOKERATIN), IMMUNOHISTOCHEMISTRY: THYROID STIMULATING HORMONE (TSH), IMMUNOHISTOCHEMISTRY: SINGLE MARKER WITHOUT IINTERPRETATION, IMMUNOFIXATION ELECTROPHORESIS (IFE), 24 HOUR URINE, IMMUNOHISTOCHEMISTRY: EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), IMMUNOHISTOCHEMISTRY: ANY 5 MARKERS WITHOUT INTERPRETATION, IMMUNOHISTOCHEMISTRY: EPITHELIAL MEMBRANE ANTIGEN (EMA), IMMUNOHISTOCHEMISTRY: ANY 3 MARKERS WITHOUT INTERPRETATION, IMMUNOHISTOCHEMISTRY: FOLLICLE STIMULATING HORMONE (FSH), IMMUNOHISTOCHEMISTRY: GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP), IMMUNOHISTOCHEMISTRY: GROWTH HORMONE (GH), IMMUNOHISTOCHEMISTRY: HEPATOCYTE SPECIFIC ANTIGEN (HSA), INSULIN FASTING (F) & POST PRANDIAL (PP) PANEL, IMMUNOGLOBULIN IgG SYNTHESIS INDEX & RATE, INTERLEUKIN-2 RECEPTOR ALPHA CHAIN; IL-2R, INTERLEUKIN 28B rs12979860 & rs 8099917 GENOTYPING QUALITATIVE PCR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: OBSTETRIC PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LYMPHOMA DIAGNOSTIC PANEL, IMMUNOHISTOCHEMISTRY: BLADDER VS PROSTATE CARCINOMA PANEL, Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUALITATIVE PCR, IMMUNOHISTOCHEMISTRY: GERM CELL TUMOR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE ANY 6 MARKERS, IMMUNOHISTOCHEMISTRY, PITUITARY ADENOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA -T, B or MYELOID, IMMUNOHISTOCHEMISTRY, PROSTATE BENIGN VS MALIGNANT PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-AML CHARACTERIZATION, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA / LYMPHOMA DIAGNOSTIC PANEL-CHRONIC LYMPHOPROLIFERATIVE DISORDERS, T & B CELL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL- CLL/HCL/SLL BASIC, IMMUNOHISTOCHEMISTRY: ANDROGEN RECEPTOR (AR), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA MONITORING PANEL-HAIRY CELL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL CUSTOMIZED ANY 10 MARKERS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-PLASMA CELL DYSCRASIAS, IMMUNOHISTOCHEMISTRY: HUMAN CHORIONIC GONADOTROPIN (HCG), IMMUNOHISTOCHEMISTRY: TRIPLE NEGATIVE BREAST CANCER (TNBC) PANEL, JAK 2 V617F REFLEX TO JAK 2 EXON 12 MUTATION DETECTION, JAK 2 V617F, CALR & MPL MUTATION DETECTION PROFILE, JAPANESE ENCEPHALITIS VIRUS (JEV) DETECTION PCR, KETONE BODY (BETA HYDROXYBUTYRATE), SERUM, KIDNEY BIOSPY / ELECTRON MICROSCOPY, SLIDES / IMAGES ISSUE, KIDNEY STONE FORMATION THERAPEUTIC MONITORING PANEL, LUNG CANCER 12 GENE PANEL WITH PDL1 - VENTANA SP263, LEUKEMIA GENETIC PROFILE: ANY 6 MARKERS PCR QUALITATIVE, LEISHMANIA (KALA AZAR) rK-39 ANTIBODY, SERUM, LUNG CANCER PANEL: 12 GENE WITH PDL1 - VENTANA SP142, LIPOPROTEIN FRACTIONATION, ULTRACENTRIFUGATION, LYME DISEASE (BORRELIA BURGDORFERI) ANTIBODIES IgG & IgM, LYME DISEASE (BORRELIA BURGDORFERI) DNA QUALITATIVE REAL TIME PCR, LYME DISEASE (BORRELIA BURGDORFERI) IgG & IgM IMMUNOBLOT, LYME DISEASE (BORRELIA BURGDORFERI) IgG IMMUNOBLOT, LYMPHOCYTE SUBSET ENUMERATION (TBNK) FOR COVID SEVERITY ASSESSMENT, LIVER KIDNEY MICROSOMAL 1 (LKM 1) ANTIBODY EIA, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IFA, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS IFA, LEGIONELLA PNEUMOPHILA IgG ANTIBODY, SERUM, LEBER'S HEREDITARY OPTIC NEUROPATHY (LHON) MITOCHONDRIAL MUTATION DETECTION, LEIGH SYNDROME MITOCHONDRIAL MUTATION DETECTION, LEPTOSPIRA ANTIBODIES PANEL IgG & IgM, EIA, LEUCOCYTE ADHESION DEFICIENCY (LAD I & II), Lp-PLA2 (LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2) ACTIVITY, LERGY SPECIFIC IgG: ASPERGILLUS FUMIGATUS, MYCOPLASMA PNEUMONIAE IgG & IgM ANTIBODIES PANEL, SERUM, MITOCHONDRIAL ANTIBODY (AMA) IFA IN DILUTIONS, MERRF (MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED RED FIBRES) MUTATION DETECTION, MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED PROFILE, MYELIN ASSOCIATED GLYCOPROTEIN (MAG) IgM, METACHROMATIC LEUCODYSTROPHY QUANTITATIVE, BLOOD, MYELOPROLIFERATIVE NEOPLASIA WITH EOSINOPHILIA, MYOSITIS PROFILE EXTENDED IgG : 16 ANTIGENS, MYELIN ASSOCIATED GLYCOPROTEIN- SULFATED GLUCURONIC PARAGLOBOSIDE AUTOANTIBODY (MAG-SGPG) IgM, METANEPHRINES FRACTIONATED, 24 HOUR URINE, METANEPHRINES FRACTIONATED, RANDOM URINE, MALARIA PARASITE / BLOOD PARASITE IDENTIFICATION, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR B-CLL, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR MULTIPLE MYELOMA, MICM (MATERNALLY INHERITED CARDIOMYOPATHY) MUTATION DETECTION, MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) MUTATION DETECTION, MICROALBUMIN/ALBUMIN, 1ST MORNING / RANDOM URINE, MITOCHONDRIAL MUTATION DETECTION COMPREHENSIVE PANEL, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT, MITOCHONDRIAL SEQUENCING: WHOLE MITOCHONDRIAL GENOME SEQUENCING, MICROALBUMIN / ALBUMIN CREATININE RATIO, URINE, MATERNAL SERUM SCREEN 2: ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA (MBFD)/NIPT CHROMOSOME 21, MIXING STUDIES: APTT WITH PROTHROMBIN TIME STUDIES, MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION; MCHC, MMC (MATERNAL MYOPATHY WITH CARDIOMYOPATHY) MUTATION DETECTION, MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) PANEL, MUMPS VIRUS ANTIBODIES PANEL IgG & IgM, SERUM, MEASLES (RUBEOLA) ANTIBODIES PANEL IgG & IgM, SERUM, MPL (MYELOPROLIFERATIVE LEUKEMIA) GENE MUTATION, MTHFR (METHYLENE TETRAHYDROFOLATE REDUCTASE) GENE MUTATION, QUALITATIVE PCR, MUCOPOLYSACCHARIDOSIS (MPS) SCREEN, URINE, MUCOPOLYSACCHARIDOSIS (MPS) TYPE 1 (HURLER) QUANTITATIVE, BLOOD, MEDULLARY THYROID CARCINOMA MUTATION DETECTION, MUCOPOLYSACCHARIDOSIS (MPS) TYPE VI (MAROTEAUX LAMY) QUANTITATIVE, BLOOD, MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS; VAN DER KNAAP AND NALBAND MLC GENE HOTSPOT MUTATION, MUCOPOLYSACCHARIDOSIS (MPS) TYPING, 24 HOUR URINE, MEMBRANOUS GLOMERULOPATHY (MGN): TARGET 5 ANTIGENS PANEL, MEMBRANOUS GLOMERULOPATHY (MGN) PLA2R NEGATIVE : TARGET 4 ANTIGENS PANEL, MYCOBACTERIUM TUBERCULOSIS PCR; MYCOSURE; TB PCR, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT WITH MICRODELETIONS, MYCOBACTERIUM TUBERCULOSIS rRNA DETECTION, TMA, NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) FIBROSIS SCORE, Nx GEN SEQUENCING: HEREDITARY RETINOBLASTOMA, Nx GEN SEQUENCING: LEBER CONGENITAL AMAUROSIS, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ULTRA, Nx GEN SEQUENCING: MEGALOENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE, Nx GEN SEQUENCING: MICROPHTHALMIA / ANOPHTHALMIA / COLOBOMA SPECTRUM, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ADVANCED, NPM1 GENE MUTATION QUANTITATIVE MRD MONITOR, NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR, NT-PRO BNP (N-TERMINAL PRO B TYPE NATRIURETIC PEPTIDE), NTx (COLLAGEN CROSS-LINKED N- TELOPEPTIDE), URINE, Nx GEN SEQUENCING: BETHLEM MYOPATHY, MYOFIBRILLAR MYOPATHY & ULLRICH MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: CHARCOT-MARIE-TOOTH DISEASE & SENSORY NEUROPATHIES, Nx GEN CLINICAL EXOME SEQUENCING, ILLUMINA, Nx GEN SEQUENCING: DRAVET'S SYNDROME & EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY, Nx GEN SEQUENCING: DUCHENNE & BECKER MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: MATURITY ONSET DIABETES OF YOUNG (MODY), Nx GEN SEQUENCING: TUBEROUS SCLEROSIS COMPLEX, Nx GEN SEQUENCING: AICARDI-GOUTIERES SYNDROME, Nx GEN SEQUENCING: AMYOTROPHIC LATERAL SCLEROSIS, NGAL (NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN), URINE, Nx GEN SEQUENCING: FAMILIAL HEMIPLEGIC MIGRAINE, Nx GEN SEQUENCING: COMPREHENSIVE EPILEPSY, OSMOTIC FRAGILITY TEST; RBC FRAGILITY TEST, ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL, ONCOMINE CHRONIC MYELOID LEUKAEMIA (CML) PANEL, ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL, ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) PANEL, ONCOMINE MYELODYSPLASTIC SYNDROME(MDS) PANEL, ONCOMINE MYELOPROLIFERATIVE NEOPLASM (MPN) PANEL, ONCOPRO COMPREHENSIVE CANCER PANEL: 161 GENES, OPPORTUNISTIC ENTERIC PARASITE SCREEN, STOOL, ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS, P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE) TOTAL, PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1), PLASMINOGEN ACTIVATOR INHIBITOR-1/SERPINE-1, 4G/5G GENOTYPING, PRIMARY IMMUNE DEFICIENCY SCREENING PANEL (PIDOT), PAN FUNGAL DETECTION AND IDENTIFICTION, PCR, PAPP-A (PREGNANCY ASSOCIATED PLASMA PROTEIN-A), PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE PCR, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUALITATIVE PCR, PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) CONFIRMATORY TEST, PARTIAL THROMBOPLASTIN TIME ACTIVATED; PTT; APTT, PROSTATE TRUS BIOPSY AI PANEL REFLEX TO IMMUNOHISTOCHEMISTRY, PARVOVIRUS B19 ANTIBODIES PANEL IgG & IgM, PORPHYRINS TOTAL QUALITATIVE, RANDOM URINE, PORPHYRINS TOTAL QUANTITATIVE, 24- HOUR URINE, PROTEIN ELECTROPHORESIS & IMMUNOTYPING, SERUM, PRADER-WILLI SYNDROME MUTATION DETECTION METHYLATION SPECIFIC PCR, PRE-ECLAMPSIA PREDICTOR (sFLT-1:PIGF RATIO) PANEL, PHOSPHATIDYLSERINE ANTIBODIES PANEL IgG & IgM, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUALITATIVE, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUANTITATIVE, PHOSPHOLIPID SYNDROME PANEL WITH BETA 2 GLYCOPROTEIN 1, IHR, PTHrP; PARATHYROID HORMONE RELATED PROTEIN, PORPHOBILINOGEN (PBG) QUANTITATIVE, 24 HOUR URINE, PURKINJE CELL (Yo) ANTIBODY SCREEN, WITH REFLEX TO TITER AND WESTERN BLOT, CSF, PCNA (PROLIFERATING CELL NUCLEAR ANTIGEN) ANTIBODY, PURKINJE CELL CYTOPLASMIC ANTIBODY TYPE Tr (DNER), PCOD (POLYCYSTIC OVARIAN DISEASE) COMPREHENSIVE PANEL, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, PIIINP (PROCOLLAGEN TYPE III AMINO TERMINAL PROPEPTIDE), Q FEVER (COXIELLA BURNETTI) ANTIBODIES IgG & IgM, QuantiFERON-TB Gold (QFT), INTERFERON GAMMA RELEASE ASSAY (IGRA), QuantiFERON-TB GOLD PLUS (QFT-PLUS), INTERFERON GAMMA RELEASE ASSAY (IGRA), ROCKY MOUNTAIN SPOTTED FEVER ANTIBODIES, ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM, RHEUMATOID AUTOIMMUNE COMPREHENSIVE PANEL, RUBELLA (GERMAN MEASLES) ANTIBODIES PANEL IgG & IgM, RS-CSARS-CoV-2 (COVID-19) ANTI-SPIKE IgG ANTIBODY QUANTITATIVE, RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIGEN, SARS-CoV-2 COVID-19 BIOMARKERS PANEL, BASIC, SARS-CoV-2 COVID-19 BIOMARKERS PANEL, EXTENDED, SARS-CoV-2 (COVID-19) NEUTRALIZING ANTIBODY, Swasthfit Advance Health Checkup - Full Body Checkup, SARS-COV-2 (COVID-19) RESPIRATORY COMPREHENSIVE PANEL, SCA-11 (SPINOCEREBELLAR ATAXIA): TTBK2 GENE MUTATION, SCA-12 (SPINOCEREBELLAR ATAXIA): PPP2R2B GENE MUTATION, SCA-17 (SPINOCEREBELLAR ATAXIA): TBP GENE MUTATION, SWASTHFIT COMPLETE PACKAGE WITH FREE WELLNESS REPORT, SCA-1 (SPINOCEREBELLAR ATAXIA): ATXN1 GENE MUTATION, SOLUBLE TRANSFERRIN RECEPTOR (sTfR), SERUM, Swasthfit Heart Check - Advance Health Checkup, SCA-2 (SPINOCEREBELLAR ATAXIA): ATXN2 GENE MUTATION, SCA-3 (SPINOCEREBELLAR ATAXIA): ATXN3 GENE MUTATION, SCA-5 (SPINOCEREBELLAR ATAXIA): SPTBN2 GENE MUTATION, SCA-6 (SPINOCEREBELLAR ATAXIA): CACNA1A GENE MUTATION, SPERM DNA FRAGMENTATION FLUORESCENT MICROSCOPY, SCA-7 (SPINOCEREBELLAR ATAXIA): ATXN7 GENE MUTATION, SCA-8 (SPINOCEREBELLAR ATAXIA): ATXN8OS & ATXN8 GENE MUTATION, Swasthfit Pro 3 (With Free Doctor Consultation), SCA (SPINOCEREBELLAR ATAXIA): COMPREHENSIVE PROFILE, SPINAL MUSCULAR ATROPHY (SMA) CARRIER DETECTION, SPINAL MUSCULAR ATROPHY (SMA) MUTATION DETECTION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgM, RAPID ASSAY, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODIES PANEL IgG & IgM, SCA (SPINOCEREBELLAR ATAXIA) PROFILE: ANY 4 MARKERS, SCA-23 (SPINOCEREBELLAR ATAXIA): PDYN GENE MUTATION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgG, EIA, SCA-14 (SPINOCEREBELLAR ATAXIA): PRKCG GENE MUTATION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgG, RAPID ASSAY, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgM, EIA, Swasthfit Total - Heart Check - Full Body Checkup, Swasthfit Total - Iron Check - Full Body Checkup, STEROID PANEL: 21- HYDROXYLASE DEFICIENCY, STEROID PANEL FOR CONGENITAL ADRENAL HYPERPLASIA (CAH), STEROID PANEL FOR PCOS / NON-CLASSICAL CAH DIFFERENTIATION, STEROID/ANDROGEN PROFILE FOR POLYCYSTIC OVARY SYNDROME (PCOS), SICKLE CELL ANEMIA TRIO PRENATAL MUTATION DETECTION, STOOL EXAMINATION HANGING DROP PREPARATION, STOOL EXAMINATION pH & REDUCING SUBSTANCES, STREPTOCOCCUS GROUP B ANTIGEN DETECTION, SARS-CoV-2 (COVID-19) ANTI-SPIKE IgG ANTIBODY PLUS, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA, SALMONELLA TYPHI AND SALMONELLA PARATYPHI A ANTIGEN DETECTION, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA IN DILUTIONS, Swasthfit Tax Saver Basic Health Checkup - Full Body Checkup, SARS-CoV-2 (COVID-19) QUALITATIVE REAL TIME RT-PCR, Swasthfit Tax Saver Advance Health Checkup - Full Body Checkup, SMOOTH MUSCLE ANTIBODY (ASMA) IFA IN DILUTIONS, SCA (SPINOCEREBELLAR ATAXIA: EXTENDED PROFILE, TOTAL WBC COUNT & DIFFERENTAL COUNT & ESR, THALASSEMIA BETA TRIO PRENATAL MUTATION DETECTION, TB LAMP (LOOP MEDIATED ISOTHERMA AMPLIFICATION) QUALITATIVE DNA PCR, MYCOBACTERIUM TUBERCULOSIS COMPLEX, TB PLATINUM INTERFERON GAMMA RELEASE ASSAY (IGRA), TOXOPLASMA ANTIBODIES PANEL IgG & IgM, SERUM, TPHA; TREPONEMA PALLIDUM HEMAGGLUTINATION, TPMT (THIOPURINE METHYL TRANSFERASE) GENOTYPING, TSH STIMULATION BY TRH (THYROTROPIN RELEASING HORMONE), TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, CORD BLOOD, TSI; THYROID STIMULATING IMMUNOGLOBULIN, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgA, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgG, TYPHUS FEVER (RICKETTSIA) ANTIBODIES IgG & IgM, TESTOSTERONE FREE & SEX HORMONE BINDING GLOBULIN, THALASSEMIA ALPHA TRIO PRENATAL MUTATION DETECTION, t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1) PCR QUALITATIVE, t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE, t(12;21) (p13;q22); ETV6-RUNX1 (TEL-AML1) PCR QUALITATIVE, t(4;11) (q21;q23); (MLL-AF4) PCR QUALITATIVE, t(11;19) (q23;p13.3); (MLL-ENL) PCR QUALITATIVE, URINE EXAMINATION ROUTINE; URINE R/E AUTOMATED, UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE 'TA' REPEATS) DETECTION, VITAMIN B1 (THIAMINE PYROPHOSPHATE), BLOOD, VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) SCREENING, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgG, CSF, VITAMIN B12 BINDING CAPACITY UNSATURATED; TRANSCOBALAMIN, VARICELLA ZOSTER VIRUS (VZV) QUALITATIVE PCR, VMA (VANILLYL MANDELIC ACID), 24 HOUR URINE, VMA (VANILLYL MANDELIC ACID), RANDOM URINE, VON WILLEBRAND FACTOR COLLAGEN BINDING ACTIVITY (vWF:CB), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, SERUM, VON WILLEBRAND FACTOR RISTOCETIN COFACTOR ACTIVITY (vWF:RCo), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, CSF, VARICELLA ZOSTER VIRUS (VZV) ANTIBODIES PANEL IgG & IgM, SERUM, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgG, SERUM, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgM, SERUM, von WILLEBRAND FACTOR ANTIGEN; vWF Ag, Y-CHROMOSOME MICRODELETION DETECTION , PCR, YEAST (CANDIDA SPECIES) SUSCEPTIBILITY TESTING.